Nikolaos Pyrsopoulos
Experienced in Hepatitis A

Dr. Nikolaos Pyrsopoulos

Transplant Surgery | Gastroenterology
33 Overlook Road, Suite 201, 
Summit, NJ 
On Staff At
Accepting New Patients
30 Years of Experience
Experienced in Hepatitis A
33 Overlook Road, Suite 201, 
Summit, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nikolaos Pyrsopoulos is a Transplant Surgeon and a Gastroenterologist in Summit, New Jersey. Dr. Pyrsopoulos has been practicing medicine for over 30 years and is rated as an Experienced provider by MediFind in the treatment of Hepatitis A. His top areas of expertise are Liver Failure, Hepatorenal Syndrome, Hepatitis, Liver Transplant, and Endoscopy. Dr. Pyrsopoulos is currently accepting new patients.

His clinical research consists of co-authoring 100 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hepatitis A.

Graduate Institution
Athens University , School Of Medicine
Residency
University of Miami Hospitals and Clinics
Specialties
Transplant Surgery
Gastroenterology
Licenses
Internal Medicine in NY
Board Certifications
American Board Of Internal Medicine
Fellowships
University of Miami
University of Miami Hospitals and Clinics
Hospital Affiliations
Overlook Medical Center
Atlantic Medical Group
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
AmeriHealth
  • EPO
  • HMO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Longevity Health Plan
  • MEDICARE SNP
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Atlantic Medical Group Gastroenterology at Summit
33 Overlook Road, Suite 201, Summit, NJ 07901
Other Locations
Atlantic Medical Group Gastroenterology at Morristown
435 South Street, Suite 230A, Morristown, NJ 07960

Additional Areas of Focus

Dr. Pyrsopoulos has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 2, Open-label, Multicenter Study to Investigate the Efficacy, Safety, and Pharmacokinetics of the Anti-PD-1 Monoclonal Antibody BGB-A317 in Patients With Previously Treated Hepatocellular Unresectable Carcinoma
A Phase 2, Open-label, Multicenter Study to Investigate the Efficacy, Safety, and Pharmacokinetics of the Anti-PD-1 Monoclonal Antibody BGB-A317 in Patients With Previously Treated Hepatocellular Unresectable Carcinoma
Enrollment Status: Completed
Publish Date: October 26, 2024
Intervention Type: Drug
Study Drug: Tislelizumab
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Drug
Study Drug: Emricasan
Study Phase: Phase 2
A Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)
A Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)
Enrollment Status: Terminated
Publish Date: January 25, 2019
Intervention Type: Biological, Other
Study Phase: Phase 3
68Gallium Citrate Imaging in Newly Diagnosed Hepatocellular Carcinoma
68Gallium Citrate Imaging in Newly Diagnosed Hepatocellular Carcinoma
Enrollment Status: Unknown
Publish Date: January 03, 2019
Intervention Type: Drug
Study Drug: 68Gallium Citrate
Study Phase: Phase 2
View 5 Less Clinical Trials

100 Total Publications

Steroid therapy is linked to lower incidence of acute kidney injury in patients with severe alcohol-associated hepatitis.
Steroid therapy is linked to lower incidence of acute kidney injury in patients with severe alcohol-associated hepatitis.
Journal: Scientific reports
Published: August 22, 2025
Similar Doctors
Kristina R. Chacko
Distinguished in Hepatitis A
Dr. Kristina R. Chacko
Transplant Surgery
Distinguished in Hepatitis A
Dr. Kristina R. Chacko
Transplant Surgery

Montefiore-Einstein Center For Transplantation

111 East 210th Street, Rosenthal 2nd Floor, 
Bronx, NY 
 (10.8 miles away)
877-287-3536
Languages Spoken:
English
See accepted insurances

Kristina R. Chacko, MD, is an Associate Professor of Medicine at the Albert Einstein College of Medicine in Bronx, NY.  She joined the Einstein-Montefiore Liver Center in 2013 after completing a fellowship in Transplant Hepatology at Mount Sinai School of Medicine in New York, NY.  She received her bachelor of arts in philosophy at Boston College and attended medical school at Baylor College of Medicine in Houston, TX.  She completed her internal medicine residency at Emory University in Atlanta, GA, and gastroenterology fellowship at New York University.  Her clinical and research interests include the diagnosis and management of alcoholic hepatitis, non-alcoholic fatty liver disease, autoimmune liver diseases, and liver transplantation.  As the program director of the ACGME-accredited transplant hepatology fellowship at Montefiore Medical Center, she is directly involved in the development and execution of the hepatology curriculum for gastroenterology and hepatology fellows. Dr. Chacko is rated as a Distinguished provider by MediFind in the treatment of Hepatitis A. Her top areas of expertise are Hepatitis, Hepatitis A, Visceromegaly, Hepatitis C, and Liver Transplant.

Distinguished in Hepatitis A
Dr. Tehseen Haider
Gastroenterology
Distinguished in Hepatitis A
Dr. Tehseen Haider
Gastroenterology

Crystal Run Healthcare Physicians Llp

300 Crystal Run Rd, 
Middletown, NY 
 (52.9 miles away)
845-692-6999
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Tehseen Haider is a Gastroenterologist in Middletown, New York. Dr. Haider is rated as a Distinguished provider by MediFind in the treatment of Hepatitis A. His top areas of expertise are Hepatitis A, Gastritis, Diarrhea, Chronic Erosive Gastritis, and Endoscopy.

Experienced in Hepatitis A
Dr. Ashley N. Tran
Transplant Surgery | Gastroenterology
Experienced in Hepatitis A
Dr. Ashley N. Tran
Transplant Surgery | Gastroenterology

Penn Liver Transplant Bethlehem

1530 8th Avenue, 
Bethlehem, PA 
 (74.9 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ashley Tran is a Transplant Surgeon and a Gastroenterologist in Bethlehem, Pennsylvania. Dr. Tran is rated as an Advanced provider by MediFind in the treatment of Hepatitis A. Her top areas of expertise are Hepatitis, Hepatitis C, Alcoholic Cirrhosis, Visceromegaly, and Endoscopy. Dr. Tran is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pyrsopoulos's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile